Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression. - Wikidata - awgldk - TriplyDB

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

http://www.wikidata.org/entity/Q37057161

about

Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu

P2860

Q55271038-8EBFBEE9-D0D2-4820-9D85-7503D5CE0715 Q58781616-8AC3E5EF-9710-4FE8-ABF1-CBBB1B906523

P2860

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

http://www.wikidata.org/entity/Q37057161

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

@en

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

@nl

type

label

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

@en

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

@nl

prefLabel

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

@en

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

@nl

P1433

Q37057161-0C92D9CC-CF50-4649-B6F3-32B4A278EC72

P1476

Q37057161-0655C0D6-EB98-490C-8DAC-8B64EE36F0D7

P2093

Q37057161-00C02759-978A-458E-A294-36D84ADA1EE7

Q37057161-1D6E9630-5591-4646-A225-9E15BD825E57

Q37057161-334A2851-9331-406D-8882-4E7D7B10BC1E

Q37057161-339C905F-1030-4289-AEDE-40714541F766

Q37057161-382A0296-ADD1-450F-934F-CC3799E12175

Q37057161-442AC116-882B-422C-90DA-07175E192A6B

Q37057161-553FD06F-EF12-4DF4-AC33-3B3C3C762F25

Q37057161-59B2DA87-00EB-4B6E-A1FC-10D3F63A1801

Q37057161-5A9307D6-3FF7-4DC4-8342-06751CE9AC92

Q37057161-5D6E2733-2EF7-4467-9617-9FD3EB94D180

P2860

Q37057161-05DC9C16-5AD0-4340-ADDE-C68D9927D34A

Q37057161-08FCA7CF-CAD4-4A57-920E-744C63A35109

Q37057161-0DD7FAFA-CCE8-41B7-A7A8-38EBAB8FDA90

Q37057161-1C93A675-1178-4E60-A179-A91C16B72319

Q37057161-286E8BED-EDBF-4B30-8F8E-0871F2A066C6

Q37057161-296D3BD8-C43E-492E-A87A-423D4315EA53

Q37057161-312D6DBA-DD99-4971-AFAE-56F254F3ADD6

Q37057161-31E6DD46-F0B5-427E-A32D-0F334C5C81DD

Q37057161-3E56FBDE-22C4-48D9-994F-21382AA1C02F

Q37057161-45361977-33AE-41E4-9A71-DF8C98831839

P304

Q37057161-D9695494-49CF-4782-B294-536909942262

P31

Q37057161-91E08ED0-BF5C-4BAC-A6B8-F77E72F6AA75

P356

Q37057161-DD2E08A5-808C-4F3E-9FFA-0D5620B2B854

P407

Q37057161-F13A6DF5-1933-4739-BBD9-16F5C672A03B

P433

Q37057161-711AD24A-2654-4295-8B67-C4803A2F1A69

P478

Q37057161-72C10412-4E86-40C4-80F0-785A3A55B7B0

P50

Q37057161-92C63EF4-C480-4126-89F7-44E7A4C02090

Q37057161-D09BD170-ABDC-432E-8CAA-739DBD5F86F4

Q37057161-FAC63D79-D266-4DB1-8786-1C79CAEABDA2

P577

Q37057161-8D3A2A10-0B58-4756-A848-005720DBFA49

P698

Q37057161-0B89415D-E9DE-41F9-9942-35970463E165

P932

Q37057161-71165CAC-DF75-4A84-A15A-1BEA3DFC0ACD

P356

J.AJPATH.2016.03.010

P1433

The American Journal of Pathology

P1476

Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression.

@en

P2093

Alexandra Müller

http://www.w3.org/2001/XMLSchema#string

Bedair Dewidar

http://www.w3.org/2001/XMLSchema#string

Bin Gao

http://www.w3.org/2001/XMLSchema#string

Carolin Stump-Guthier

http://www.w3.org/2001/XMLSchema#string

Chaohui Yu

http://www.w3.org/2001/XMLSchema#string

Chengfu Xu

http://www.w3.org/2001/XMLSchema#string

Christoph Meyer

http://www.w3.org/2001/XMLSchema#string

Frank Lammert

http://www.w3.org/2001/XMLSchema#string

Hai Li

http://www.w3.org/2001/XMLSchema#string

Hong-Lei Weng

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the human Jagged1 gene are responsible for Alagille syndrome

Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1

Cellular and molecular mechanisms of fibrosis

Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis

Animal models of chronic liver diseases

IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling

The canonical Notch signaling pathway: unfolding the activation mechanism.

Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells

Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia.

Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling.

P304

1874-1889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2016.03.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P50

Hellmut G Augustin

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27171900

http://www.w3.org/2001/XMLSchema#string

P932

4929401

http://www.w3.org/2001/XMLSchema#string